are they banning tirzepatide Lilly's weight-loss drug removed from FDA's shortage list Zepbound copycats remain online despite

Retatrutide and high blood pressure: discover how this investigational triple receptor agonist may affect blood pressure, what clinical trial evidence shows, who should exercise caution, and the current UK regulatory position.

A population-based cohort study of nearly 114,000 patients with T2D found that use of GLP-1s, compared with SGLT-2 inhibitors, was associated with a 27% higher relative risk of being diagnosed with GERD and a 55% higher relative risk of GERD-related complications

Retatrutide loses 28% vs Foundayo's 11%

PAD is a condition in which arteries become narrowed due to the buildup of fatty deposits, reducing blood flow to the limbs, most commonly the legs...

In this definitive guide, we detail everything to know about Tirzepatide in Arlington, VA.

Plus: other alternatives worth exploring to accelerate your weight-loss goals.